Nuo Therapeutics Stock Price Prediction
| AURX Stock | USD 2.01 0.14 6.51% |
Momentum 42
Sell Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Nuo Therapeutics based on different types of headlines from major news networks to social media. Using Nuo Therapeutics hype-based prediction, you can estimate the value of Nuo Therapeutics from the perspective of Nuo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Nuo Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Nuo Therapeutics to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Nuo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nuo Therapeutics after-hype prediction price | USD 2.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nuo |
Nuo Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Nuo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nuo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Nuo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nuo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Nuo Therapeutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nuo Therapeutics' historical news coverage. Nuo Therapeutics' after-hype downside and upside margins for the prediction period are 0.11 and 9.26, respectively. We have considered Nuo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nuo Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Nuo Therapeutics is based on 3 months time horizon.
Nuo Therapeutics OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Nuo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nuo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nuo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.28 | 7.10 | 0.00 | 0.01 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.01 | 2.15 | 0.00 |
|
Nuo Therapeutics Hype Timeline
Nuo Therapeutics is presently traded for 2.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Nuo is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.28%. %. The volatility of related hype on Nuo Therapeutics is about 28400.0%, with the expected price after the next announcement by competition of 2.00. About 55.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Nuo Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Nuo Therapeutics Basic Forecasting Models to cross-verify your projections.Nuo Therapeutics Related Hype Analysis
Having access to credible news sources related to Nuo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Nuo Therapeutics' future price movements. Getting to know how Nuo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nuo Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KNTPF | Kintor Pharmaceutical Limited | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 22.36 | |
| PBIGF | Paradigm Biopharmaceuticals Limited | 0.00 | 0 per month | 5.49 | 0.07 | 16.67 | (13.33) | 60.62 | |
| POLBF | Poolbeg Pharma PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HOFBF | Hofseth BioCare ASA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MSCLF | Satellos Bioscience | 0.00 | 0 per month | 3.20 | 0.04 | 8.00 | (5.77) | 18.87 | |
| VSBC | VitaSpring Biomedical Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IUGNF | Imugene Limited | 0.00 | 0 per month | 5.36 | 0.06 | 20.00 | (9.09) | 41.90 | |
| GGBXF | Green Growth Brands | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RCEL | Avita Medical | (0.25) | 7 per month | 0.00 | (0.14) | 4.27 | (4.84) | 30.03 | |
| SPHRY | Starpharma Holdings | 0.00 | 0 per month | 2.55 | 0.16 | 9.68 | (6.25) | 31.32 |
Nuo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Nuo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nuo using various technical indicators. When you analyze Nuo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nuo Therapeutics Predictive Indicators
The successful prediction of Nuo Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nuo Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nuo Therapeutics based on analysis of Nuo Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nuo Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nuo Therapeutics's related companies.
Story Coverage note for Nuo Therapeutics
The number of cover stories for Nuo Therapeutics depends on current market conditions and Nuo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nuo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nuo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Nuo OTC Stock Analysis
When running Nuo Therapeutics' price analysis, check to measure Nuo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuo Therapeutics is operating at the current time. Most of Nuo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nuo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuo Therapeutics' price. Additionally, you may evaluate how the addition of Nuo Therapeutics to your portfolios can decrease your overall portfolio volatility.